Bio Pharma Dive
APRIL 11, 2021
Study results presented at AACR showed Retevmo shrank tumors in nine different cancers, building a case for the type of tissue-agnostic label that only three other medicines have secured.
World of DTC Marketing
APRIL 11, 2021
QUICK THOUGHT: People believe the COVID-19 vaccine was developed in less than a year but that’s not true. Coronaviruses were first encountered in April 1930, when a strange respiratory disease ravaged poultry farms across North Dakota and Minnesota, killing tens of thousands of baby birds. Further scientific research into the virus and recognition that it was not like influenza A, a flu virus known to cause bronchitis, would transpire over the next 30 years. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
APRIL 11, 2021
Researchers are leveraging the messenger RNA (mRNA) technology used to develop the Pfizer-BioNTech and Moderna COVID-19 vaccines for possible treatments for a range of other diseases, including HIV and cancer.
Scienmag
APRIL 11, 2021
Credit: Julius Csotonyi April12, 2021 – Gray wolves are among the largest predators to have survived the extinction at the end of the last ice age around11,700 years ago. Today, they can be found roaming Yukon’s boreal forest and tundra, with caribou and moose as their main sources of food. A new study led by […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
APRIL 11, 2021
Six months after a COVID-19 diagnosis, more than 33% of people exhibited some form of brain damage, according to a study appearing in Lancet Psychiatry.
Scienmag
APRIL 11, 2021
Credit: MD Anderson Cancer Center HOUSTON — Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers, high-grade (HGG) and low-grade glioma (LGG) and ovarian cancer. The results, presented today at the virtual American Association for Cancer Research (AACR) Annual […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
APRIL 11, 2021
Credit: Kim Ratliff, Augusta University Augusta University has received a $1.5 million grant from the National Institutes of Health to help support the graduate education of future scientists whose focus is cardiometabolic diseases — like hypertension and diabetes — which disproportionally affect minorities. The training grant (1HL155011-01A1) will support four graduate students in its first […].
BioSpace
APRIL 11, 2021
The new factory will include cutting-edge technology, allowing production of three to four vaccines simultaneously, a massive improvement on the current limitation of one vaccine in an industrial site.
Scienmag
APRIL 11, 2021
Study: “How Do Weighted Funding Formulas Affect Charter School Enrollments?” Author: Paul Bruno (University of Illinois at Urbana-Champaign) This study was presented today at the American Educational Research Association’s 2021 Virtual Annual Meeting. Main Findings: The adoption of a school funding system in California that increased revenues for schools enrolling higher-need students led to an […].
BioSpace
APRIL 11, 2021
Recently announced topline results from a Phase II study show SAGE-324, Sage Therapeutics’ investigational oral neuroactive steroid GABAA receptor positive allosteric modulator, significantly reduced tremor score in adult patients with essential tremor.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
JAMA Internal Medicine
APRIL 11, 2021
This quality improvement study uses data from medical intensive care units to investigate the association between time-limited trials and nonbeneficial treatments.
BioSpace
APRIL 11, 2021
Taysha Gene Therapies has acquired exclusive global rights to TSHA-120, an intrathecally dosed AAV9 gene therapy designed to treat giant axonal neuropathy.
Druggist
APRIL 11, 2021
Amoxicillin is one of the most prescribed antibiotics in the UK. On the contrary, metronidazole is significantly less prescribed by GPs, mainly because of preferred use in dental infections. Prescriptions which are fulfilled in the pharmacy for a combination treatment with amoxicillin and metronidazole are almost always issued by a dentist rather than GP.
BioSpace
APRIL 11, 2021
In a flurry of weekend activity, oncology companies showcased the latest clinical and preclinical data for cancer therapies during the virtual American Association for Cancer Research meeting.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
APRIL 11, 2021
Steaming service will be embedded into academic modules of University’s new BA (Hons) Esports degree Credit: University of Chichester Twitch-Chichester agreement will equip students with skills and experience necessary to participate in global esports and gaming industry Steaming service will be embedded into academic modules of University’s new BA (Hons) Esports degree Students will get […].
BioSpace
APRIL 11, 2021
It was a relatively quiet week for clinical trial announcements, but there were a few standouts. Read on for more.
Scienmag
APRIL 11, 2021
Multimillion-dollar program dedicates funds to advance understanding of bipolar disorder treatment options. Initial letters of intent due May 14, 2021. Credit: Milken Institute The Milken Institute’s Center for Strategic Philanthropy and the Baszucki Brain Research Fund today announced the launch of a dedicated grant program aimed at advancing therapeutic discovery for bipolar disorder (BD).
BioSpace
APRIL 11, 2021
Regeneron Pharmaceuticals announced the results from its Phase III trial of recently infected asymptomatic COVID-19 patients for its REGEN-COV (casirivimab with imdevimab) antibody cocktail.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
The Pharma Data
APRIL 11, 2021
Confirmed Objective Response Rate of 47 Percent, with Responses Observed in Nine Unique Cancer Types Median Duration of Response Not Reached at 13 Months Median Follow-Up, with 11 of 15 Responses Ongoing Safety Consistent with Known Profile of Retevmo New Data Expands on Retevmo’s Established Data in Lung and Thyroid Cancers. INDIANAPOLIS, April 11, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced for the first time data from the Phase 1/2 LIBRETTO-001 trial show
BioSpace
APRIL 11, 2021
The U.S. Food and Drug Administration’s schedule for April has several PDUFA dates scattered across the rest of the month. Here’s a look.
Drug Patent Watch
APRIL 11, 2021
Annual Drug Patent Expirations for ALTABAX Altabax is a drug marketed by Almirall and is included in one NDA. It is available from one supplier. There are three patents protecting…. The post New patent expiration for Almirall drug ALTABAX appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
APRIL 11, 2021
The three posters OncoMyx Therapeutics presented at the virtual American Association for Cancer Research (AACR) Virtual Annual Meeting on April 10th provided the first data indicating its myxoma virotherapy approach to oncolytic therapeutics.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Drug Patent Watch
APRIL 11, 2021
Annual Drug Patent Expirations for ERAXIS Eraxis is a drug marketed by Vicuron and is included in one NDA. It is available from one supplier. There are three patents protecting…. The post New patent expiration for Vicuron drug ERAXIS appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 11, 2021
Lessons learned during COVID-19 can aid workplace communication during crises and normal times Workplace communication often took a back seat this past year, as employees and employers rushed to work remotely, struggled with technology barriers and adjusted to physical distancing. But the pandemic has resulted in valuable lessons for communicating on the job, according to […].
Drug Patent Watch
APRIL 11, 2021
Annual Drug Patent Expirations for REQUIP+XL Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven…. The post New patent expiration for Glaxosmithkline Llc drug REQUIP XL appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 11, 2021
People who trust television and Facebook to provide them with accurate news about the coronavirus pandemic are less knowledgeable about COVID-19, according to a new study, which assessed people’s knowledge of the virus in the earliest stages of the pandemic. The study, published today in the peer-reviewed journal Current Medical Research & Opinion, surveyed 5,948 […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioTech 365
APRIL 11, 2021
Valbiotis Reveals Positive TOTUM•854 Preclinical Results in the Prevention of Hypertension at the Annual ESH-ISH Joint Meeting Valbiotis Reveals Positive TOTUM•854 Preclinical Results in the Prevention of Hypertension at the Annual ESH-ISH Joint Meeting An acceleration of development in order … Continue reading →
Scienmag
APRIL 11, 2021
Researchers have found common foxgloves brought to the Americas have rapidly evolved to change flower length in the presence of a new pollinator group, hummingbirds. The findings are published in the British Ecological Society’s Journal of Ecology. Researchers from the University of Sussex, Universidad de Los Andes (Colombia) and Universidad de Costa Rica, studying the […].
BioTech 365
APRIL 11, 2021
HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity ABEC stainless steel fermentation solutions to enhance HEC Pharm’s manufacturing productivity and flexibility BETHLEHEM, Pa.
Scienmag
APRIL 11, 2021
A recent study indicates that a U.S. ban on the use of tanning beds among minors would prevent thousands of cases of melanoma in adolescents and would save millions of dollars in healthcare costs. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Indoor tanning has been linked […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
328 
Let's personalize your content